An EU-and industry-funded project has created an integrated platform which is providing an innovative range of free services, expertise and a huge collection of compounds for researchers who are developing new drugs to treat all types of human diseases.
EU-funded researchers have developed a treatment tailored for babies and children lacking the stress hormone cortisol. The drug, the first hydrocortisone formulation specifically designed for infants, could become available next year following successful clinical trials.
EU-funded research has shown how skin cells can warn our immune systems of an impending bacterial attack, offering the potential for vaccines against antibiotic-resistant infections that could save lives.
Do people living with HIV age more quickly, despite the fact that their infection is well controlled? Concerns have emerged in recent years, and an EU-funded study was launched to look into the matter by exploring links with age-related conditions, with a specific focus on cognitive impairment. No acceleration was observed.
Rapid diagnosis is vital for controlling outbreaks of the deadly Ebola virus. Currently this can only be done in complex laboratories and samples from infected patients are dangerous to handle and transport. Faced with this challenge, an EU and industry-funded project is developing fast, local tests to spot infection quickly and safely, helping to contain its spread and saving lives in the process.
The EU-funded SWEETOOLS project aims to improve our understanding of the role of sugars in human biology. Exploring optimised versions of biosynthesised proteins combined with chemically synthesised drugs could help the development of novel biomedicines and vaccines targeting, for example, influenza.
EU-funded researchers have developed an efficient colorectal cancer treatment that can prevent relapses in patients post-surgery. It involves applying drugs that kill cancer cells directly to the tumour site, eliminating the need for unpleasant, ongoing injections that can cause side effects.
EU-funded researchers have pioneered new techniques to treat type 1 diabetes, which on their own have significant market potential. Taken together, these breakthroughs could lead to effective cell-based treatments of a condition that affects millions of people.
EU and industry-funded research into validating more imaging biomarkers for use in cancer drug trials seeks to speed up development of successful new drugs and avoid exposing patients to treatment that does not work for them.
An EU-funded project is carrying out the first clinical trial among elderly cardiac patients of a novel multi-medication pill to prevent recurrent heart attacks, improve the efficacy of care and save lives.
